PTAB Decides that the Petitioner has Shown by a Preponderance of the Evidence that the Challenged Claims of a MRI Technology Patent are Unpatentable

On  June 26, 2017, In a final written decision, the Board found claims of a patent directed to MRI technology unpatentable under 35 U.S.C. § 102(b) because Petitioner was able to demonstrate by a preponderance of the evidence that a conference paper disclosed each limitation of many of the claims either expressly or inherently.  The Board also found the claims of a patent unpatentable under 35 U.S.C. § 103(a) because the petitioner was able to show that the claims were obvious in light of the conference paper and a textbook that teaches expressly each limitation that the conference paper discloses inherently for anticipation purposes.  However, the Board found an asserted reference was not prior art under 35 U.S.C. § 102(a).  The patent at issue is U.S. Patent No. RE44,644 E, which relates to nuclear magnetic resonance imaging (“MRI”) technology.  The IPR number is 2016-00357

By: Becky E. Steephenson